MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer

by Zhi Cao, Jin Ji, Fu-Bo Wang, Chen Kong, Huan Xu, Ya-Long Xu, Xi Chen, Yong-Wei Yu, Ying-Hao Sun
Published 2020-01-01

Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review

by De-Pei Kong, Rui Chen, Chun-Lei Zhang, Wei Zhang, Guang-An Xiao, Fu-Bo Wang, Na Ta, Xu Gao, Ying-Hao Sun
Published 2020-01-01

PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium

by Zi-Jian Song, Jin-Ke Qian, Yue Yang, Han-Xiao Wu, Mao-Yu Wang, Si-Yuan Jiang, Fu-Bo Wang, Wei Zhang, Rui Chen, Chinese Prostate Cancer Consortium
Published 2021-01-01

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy

by Fu-Bo Wang, Rui Chen, Shan-Cheng Ren, Xiao-Lei Shi, Ya-Sheng Zhu, Wei Zhang, Tai-Le Jing, Chao Zhang, Xu Gao, Jian-Guo Hou, Chuan-Liang Xu, Ying-Hao Sun
Published 2017-01-01

Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion

by Yi Sun, Min Wei, Shan-Cheng Ren, Rui Chen, Wei-Dong Xu, Fu-Bo Wang, Ji Lu, Ji Lu, Jian Shen, Yong-Wei Yu, Jian-Guo Hou, Chuan-Liang Xu, Jiao-Ti Huang, Ying-Hao Sun
Published 2014-04-01

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1

by Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, Li-Ping Xie, Yi-Ran Huang, Da-Lin He, Xu Gao, Chuan-Liang Xu, Qiang Ding, Qiang Wei, Chang-Jun Yin, Shan-Cheng Ren, Fu-Bo Wang, Ye Tian, Zhong-Quan Sun, Qiang Fu, Lu-Lin Ma, Jun-Hua Zheng, Zhang-Qun Ye, Ding-Wei Ye, Dan-Feng Xu, Jian-Quan Hou, Ke-Xin Xu, Jian-Lin Yuan, Xin Gao, Chun-Xiao Liu, Tie-Jun Pan, Ying-Hao Sun, on behalf of Chinese Prostate Cancer Consortium
Published 2015-01-01